Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1957 5
1958 4
1959 1
1960 2
1962 4
1963 1
1964 4
1965 3
1966 2
1967 1
1968 2
1969 3
1970 3
1971 4
1972 7
1973 8
1974 4
1975 9
1976 6
1977 2
1978 11
1979 12
1980 14
1981 12
1982 28
1983 19
1984 19
1985 26
1986 36
1987 32
1988 46
1989 47
1990 53
1991 36
1992 87
1993 70
1994 88
1995 83
1996 89
1997 88
1998 98
1999 99
2000 119
2001 104
2002 152
2003 185
2004 196
2005 276
2006 315
2007 325
2008 347
2009 368
2010 447
2011 565
2012 556
2013 619
2014 739
2015 806
2016 853
2017 977
2018 1046
2019 1199
2020 1499
2021 1704
2022 1933
2023 1882
2024 2107
2025 612

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,838 results

Results by year

Filters applied: . Clear all
Page 1
Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response.
Qiu MZ, Wang C, Wu Z, Zhao Q, Zhao Z, Huang CY, Wu W, Yang LQ, Zhou ZW, Zheng Y, Pan HM, Liu Z, Zeng ZL, Luo HY, Wang F, Wang FH, Yang SY, Huang MX, Lian Z, Zhang H, Xu RH. Qiu MZ, et al. Among authors: huang mx. Signal Transduct Target Ther. 2023 Sep 21;8(1):370. doi: 10.1038/s41392-023-01622-1. Signal Transduct Target Ther. 2023. PMID: 37735150 Free PMC article.
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy.
Wang C, Huang M, Lin Y, Zhang Y, Pan J, Jiang C, Cheng M, Li S, He W, Li Z, Tu Z, Fan J, Zeng H, Lin J, Wang Y, Yao N, Liu T, Qi Q, Liu X, Zhang Z, Chen M, Xia L, Zhang D, Ye W. Wang C, et al. Among authors: huang m. Nat Metab. 2023 Oct;5(10):1765-1786. doi: 10.1038/s42255-023-00883-y. Epub 2023 Sep 4. Nat Metab. 2023. PMID: 37667133
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial.
Liu H, Zeng Z, Zhang H, Wu M, Ma D, Wang Q, Xie M, Xu Q, Ouyang J, Xiao Y, Song Y, Feng B, Xu Q, Wang Y, Zhang Y, Hao Y, Luo S, Zhang X, Yang Z, Peng J, Wu X, Ren D, Huang M, Lan P, Tong W, Ren M, Wang J, Kang L; Chinese Transanal Endoscopic Surgery Collaborative (CTESC) Group. Liu H, et al. Among authors: huang m. Ann Surg. 2023 Jan 1;277(1):1-6. doi: 10.1097/SLA.0000000000005523. Epub 2022 Jul 11. Ann Surg. 2023. PMID: 35815886 Free PMC article. Clinical Trial.
Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade.
He Y, Wang H, Lin S, Chen T, Chang D, Sun Y, Wang C, Liu Y, Lu Y, Song J, Li S, Xu W, Lin Y, Zheng Y, Zhou X, Huang Q, Huang M. He Y, et al. Among authors: huang m. Biomed Pharmacother. 2023 Sep;165:115279. doi: 10.1016/j.biopha.2023.115279. Epub 2023 Aug 4. Biomed Pharmacother. 2023. PMID: 37544281 Free article.
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.
Zhou X, Zhou L, Yao Z, Huang M, Gong Y, Zou B, Zhu J, Liu Y, Peng F, Zhang Y, Yu M, Li Y, Na F, Wu Y, Kang K, Xiu W, Zhang X, Zhou L, Xu Y, Wang J, Wang Y, Yang X, Wu Y, Li R, Zhang Y, Yang Z, Zhou Z, Bai J, Yi X, Tong R, Yin L, Chen C, Niedermann G, Lu Y, Xue J. Zhou X, et al. Among authors: huang m. Clin Cancer Res. 2023 Oct 13;29(20):4098-4108. doi: 10.1158/1078-0432.CCR-23-0315. Clin Cancer Res. 2023. PMID: 37581611
18,838 results
You have reached the last available page of results. Please see the User Guide for more information.